Genmab A/S
GMAB
$31.94
$0.601.91%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 28.91% | -15.31% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 28.91% | -15.31% | |||
| Cost of Revenue | 29.23% | -19.75% | |||
| Gross Profit | 28.88% | -14.94% | |||
| SG&A Expenses | 23.49% | -20.19% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 11.48% | -17.67% | |||
| Operating Income | 80.89% | -7.41% | |||
| Income Before Tax | 298.65% | 34.55% | |||
| Income Tax Expenses | -138.10% | -12.50% | |||
| Earnings from Continuing Operations | 471.70% | 70.97% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 471.70% | 70.97% | |||
| EBIT | 80.89% | -7.41% | |||
| EBITDA | 73.36% | -3.56% | |||
| EPS Basic | 488.10% | 66.87% | |||
| Normalized Basic EPS | 182.67% | -50.99% | |||
| EPS Diluted | 491.57% | 65.93% | |||
| Normalized Diluted EPS | 184.35% | -50.37% | |||
| Average Basic Shares Outstanding | -2.79% | 2.46% | |||
| Average Diluted Shares Outstanding | -3.36% | 1.17% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||